We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.65B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+22.9%
3 Year Est. Return
+58.88%
5 Year Est. Return
+87.69%
10 Year Est. Return
+260.41%
AUM
$1.48B
AUM Growth
-$4.9M
Cap. Flow
-$12.2M
Cap. Flow %
-0.83%
Top 10 Hldgs %
51.78%
Holding
106
New
4
Increased
15
Reduced
58
Closed
9

Top Buys

Rank Stock Value
1
RTO icon
Rentokil
RTO
+$1.37M
2
GPN icon
Global Payments
GPN
+$860K
3
IQV icon
IQVIA
IQV
+$823K
4
TMO icon
Thermo Fisher Scientific
TMO
+$822K
5
GEV icon
GE Vernova
GEV
+$756K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.64M
2
PG icon
Procter & Gamble
PG
+$1.53M
3
MMM icon
3M
MMM
+$1.34M
4
MSFT icon
Microsoft
MSFT
+$1.28M
5
GE icon
GE Aerospace
GE
+$1.17M

Sector Composition

Rank Sector Weight
1 Technology 30.91%
2 Healthcare 21.26%
3 Consumer Staples 11.17%
4 Communication Services 8.13%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$129B
$17.3M 1.17%
50,813
-200
-0.4% -$67.7K
ALC icon
27
Alcon
ALC
$33.9B
$15.8M 1.07%
177,298
+103
+0.1% +$8.79K
CSCO icon
28
Cisco
CSCO
$476B
$15.7M 1.06%
330,837
-3,789
-1% -$180K
SO icon
29
Southern Company
SO
$107B
$14.9M 1.01%
192,302
MDT icon
30
Medtronic
MDT
$110B
$13M 0.88%
165,287
+25
+0% +$2.05K
APD icon
31
Air Products & Chemicals
APD
$66.8B
$11.5M 0.78%
44,546
+662
+2% +$168K
TMO icon
32
Thermo Fisher Scientific
TMO
$214B
$11.3M 0.77%
20,523
+1,434
+8% +$822K
CVS icon
33
CVS Health
CVS
$123B
$10.8M 0.73%
183,380
-26,199
-13% -$1.64M
XOM icon
34
ExxonMobil
XOM
$642B
$9.33M 0.63%
81,072
-673
-0.8% -$78.4K
GPN icon
35
Global Payments
GPN
$24B
$8.73M 0.59%
90,245
+7,809
+9% +$860K
AZPN
36
DELISTED
Aspen Technology Inc
AZPN
$6.05M 0.41%
30,457
+1,042
+4% +$214K
EXPD icon
37
Expeditors International
EXPD
$23.2B
$5.55M 0.37%
44,466
-9,061
-17% -$1.08M
WDS icon
38
Woodside Energy
WDS
$43.2B
$4.86M 0.33%
258,480
+1,031
+0.4% +$19.2K
ABBV icon
39
AbbVie
ABBV
$431B
$4.67M 0.32%
27,235
-705
-3% -$117K
STT icon
40
State Street
STT
$50.8B
$4.58M 0.31%
61,937
-1,900
-3% -$142K
JPM icon
41
JPMorgan Chase
JPM
$947B
$4.52M 0.31%
22,362
-1,372
-6% -$268K
NVDA icon
42
NVIDIA
NVDA
$5.3T
$4.32M 0.29%
34,940
EMR icon
43
Emerson Electric
EMR
$87.5B
$4.21M 0.28%
38,257
-3,830
-9% -$423K
NVS icon
44
Novartis
NVS
$293B
$4.02M 0.27%
37,802
-5,494
-13% -$551K
GE icon
45
GE Aerospace
GE
$389B
$3.88M 0.26%
24,411
-7,322
-23% -$1.17M
ABT icon
46
Abbott
ABT
$187B
$3.8M 0.26%
36,562
-300
-0.8% -$31.8K
COST icon
47
Costco
COST
$421B
$3.72M 0.25%
4,380
-2
-0% -$1.56K
ECL icon
48
Ecolab
ECL
$79.8B
$3.72M 0.25%
15,632
-1,097
-7% -$253K
MKC icon
49
McCormick & Company Non-Voting
MKC
$14.1B
$3.35M 0.23%
47,217
-1,355
-3% -$98.6K
BHP icon
50
BHP
BHP
$223B
$3.14M 0.21%
55,064
-900
-2% -$52.3K

Similar funds

Nichols & Pratt Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Nichols & Pratt Advisers held 106 positions worth $1.48B, down 0.33% from $1.48B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Nichols & Pratt Advisers's Q2 2024 filing shows 4 new, 15 increased, 58 reduced and 9 closed positions. Its largest new stake was GE Vernova: 4,773 shares worth $819K. The largest sale was CVS Health, an estimated $1.64M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2024 buy was GE Vernova: 4,773 shares worth $819K.
  • Nichols & Pratt Advisers added most to Rentokil in Q2 2024, an estimated $1.37M increase.
  • Nichols & Pratt Advisers's biggest Q2 2024 reduction was CVS Health, cutting an estimated $1.64M.
  • Nichols & Pratt Advisers fully exited Estee Lauder in Q2 2024, selling an estimated $310K.
  • Nichols & Pratt Advisers's ten largest holdings make up 52% of its $1.48B portfolio in Q2 2024.
  • Nichols & Pratt Advisers opened 4 new positions and closed 9 in Q2 2024.
  • Nichols & Pratt Advisers's portfolio value fell 0.33% quarter-over-quarter to $1.48B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2024, filed 25 Jul 2024.